Učitavanje...
Targeting NAMPT as a therapeutic strategy against stroke
Stroke is the second and the leading most common cause of death in the world and China, respectively, but with few effective therapies. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD) salvage synthesis in mammals, thereby influen...
Spremljeno u:
| Izdano u: | Stroke Vasc Neurol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6613878/ https://ncbi.nlm.nih.gov/pubmed/31338216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2018-000199 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|